ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Virpax Pharmaceuticals Inc

Virpax Pharmaceuticals Inc (VRPX)

2.65
-0.12
(-4.33%)
Closed April 30 4:00PM
2.64
-0.01
( -0.38% )
Pre Market: 9:25AM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
2.64
Bid
2.52
Ask
2.65
Volume
100
0.00 Day's Range 0.00
2.402 52 Week Range 11.774
Market Cap
Previous Close
2.65
Open
-
Last Trade Time
08:10:47
Financial Volume
-
VWAP
-
Average Volume (3m)
54,069
Shares Outstanding
1,171,428
Dividend Yield
-
PE Ratio
-0.20
Earnings Per Share (EPS)
-12.97
Revenue
-
Net Profit
-15.19M

About Virpax Pharmaceuticals Inc

Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray. Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
Virpax Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker VRPX. The last closing price for Virpax Pharmaceuticals was $2.65. Over the last year, Virpax Pharmaceuticals shares have traded in a share price range of $ 2.402 to $ 11.774.

Virpax Pharmaceuticals currently has 1,171,428 shares outstanding. The market capitalization of Virpax Pharmaceuticals is $3.10 million. Virpax Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.20.

VRPX Latest News

Virpax Announces Results of Maximum Tolerated Dose Study for Probudur™

-Liposomal Formulation Developed to Provide Both Immediate and Sustained Pain Relief- Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in...

Virpax Pharmaceuticals Reports 2023 Year-End Results

Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central...

Virpax Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price

Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central...

Virpax Pharmaceuticals Announces Proposed Settlement of Litigation with Sorrento Therapeutics, Inc. and Scilex Pharmaceuticals, Inc.

Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central...

Virpax Pharmaceuticals Announces Preliminary Results of ProbudurTM Pilot Study with the U.S. Army Institute of Surgical Research

Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.43-14.0065146583.073.3652.5111692.81768279CS
4-1.5-36.2318840584.144.23942.591973.41339344CS
12-1.38-34.3283582094.025.482.5540693.77418092CS
26-4.97124-65.31445598887.6112482.4021712473.80653939CS
52-4.199-61.3978651856.83911.7742.402990734.57059034CS
156-38.56-93.592233009741.2359.7992.402710846103.77303875CS
260-77.36-96.780359.7992.402677452102.75261676CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AAGRAfrican Agriculture Holdings Inc
$ 0.3445
(0.00%)
962
AADRAdvisorShares Dorsey Wright ADR ETF
$ 61.0191
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.92
(0.00%)
2
AACIArmada Acquisition Corporation I
$ 11.56
(0.00%)
85
AACGATA Creativity Global
$ 0.89
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.3445
(0.00%)
962
AADRAdvisorShares Dorsey Wright ADR ETF
$ 61.0191
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.92
(0.00%)
2
AACIArmada Acquisition Corporation I
$ 11.56
(0.00%)
85
AACGATA Creativity Global
$ 0.89
(0.00%)
0
AKANAkanda Corporation
$ 0.093
(0.00%)
78.34M
CTMXCytomX Therapeutics Inc
$ 1.63
(0.00%)
13.83M
IMCCIM Cannabis Corporation
$ 0.86
(0.00%)
11.69M
FFIEFaraday Future Intelligent Electric Inc
$ 0.0441
(0.00%)
10.83M
SQQQProShares UltraPro Short QQQ
$ 11.95
(0.00%)
5.62M

VRPX Discussion

View Posts
Renee Renee 2 months ago
VRPX: effective March 1,2024 a one for 10 reverse split:

https://hedgefollow.com/upcoming-stock-splits.php
👍️0
glenn1919 glenn1919 5 months ago
VRPX...........................................https://stockcharts.com/h-sc/ui?s=VRPX&p=W&b=5&g=0&id=p86431144783
👍️0
TheFinalCD TheFinalCD 5 months ago
whats the latest here? https://finviz.com/quote.ashx?t=VRPX&ty=c&ta=1&p=d
👍️0
StockLogistics StockLogistics 2 years ago
“ Litigation

From time to time the Company is subject to claims by third parties under various legal disputes. The defense of such claims, or any adverse outcome relating to any such claims, could have a material adverse effect on the Company’s liquidity, financial condition and cash flows.

On March 12, 2021, the Company and Mr. Mack (the “Defendants”) were named as defendants in a complaint (the “Complaint”) filed by Sorrento Therapeutics, Inc. (“Sorrento”), and Scilex Pharmaceuticals Inc. (“Scilex” and together with Sorrento, the “Plaintiffs”) in the Court of Chancery of the State of Delaware. In the Complaint, the Plaintiffs alleged (i) Mr. Mack breached a Restrictive Covenants Agreement, dated as of November 8, 2016, between himself and Sorrento (the “Restrictive Covenants Agreement”), (ii) the Company tortiously interfered with the Restrictive Covenants Agreement, and (iii) the Company tortiously interfered with Scilex’s relationship with Mr. Mack. On May 7, 2021 Plaintiffs filed an Amended Complaint (the “First Amended Complaint”) asserting the same three causes of action. Simultaneously with filing the original Complaint, Plaintiffs filed a motion to expedite, seeking a hearing on their prospective motion for a preliminary injunction, prohibiting Mr. Mack’s alleged violations of the Restrictive Covenants Agreement and prohibiting the alleged tortious interference. On March 22, 2021, Vice Chancellor Paul A. Fioravanti Jr. issued a scheduling order, setting forth terms which had been agreed to by the parties, under which oral argument on Plaintiffs’ proposed motion for preliminary injunction was scheduled for July 15, 2021. On May 18, 2021, the Vice Chancellor issued a revised scheduling order, also setting forth terms which had been agreed to by the parties, under which Plaintiffs agreed not to move for a preliminary injunction and a trial in the action was set for February 9-11, 2022. On September 28, 2021, Plaintiffs filed a Second Amended Verified Complaint asserting the same three causes of action as the prior complaints, as well as additional claims in which Plaintiffs allege (i) Mr. Mack breached an Employment, Proprietary Information and Inventions Agreement, dated as of October 25, 2016, between himself and Sorrento (the “Employment Agreement”), (ii) the Company tortiously interfered with the Employment Agreement, (iii) Mr. Mack breached his fiduciary duties to Scilex, and (iv) the Company aided and abetted Mr. Mack’s alleged breach of fiduciary duties to Scilex. On October 18, 2021, Defendants filed an Answer to the Second Amended Complaint, and subsequently withdrew a previously filed motion to dismiss the first Amended Complaint. We intend to vigorously defend the action. However, we are unable to predict the ultimate outcome of the lawsuit at this time.


- From the quarterly filing
👍️0
Awl416 Awl416 2 years ago
News
👍️0
JMoneyHoops JMoneyHoops 2 years ago
Adding here
👍️0
ok2buy ok2buy 3 years ago
Company just screwed existing share holders with a $6.00 placement. Shame on you./ok2
👍️0
ok2buy ok2buy 3 years ago
Halted this morning pending news. On my watchlist./ok2
👍️0
ok2buy ok2buy 3 years ago
Back in on the buy, thanks to the seller./ok2
👍️0
ok2buy ok2buy 3 years ago
Also extremely low float on this one. Big money looking to steal your shares today if you let them./ok2
👍️0
ok2buy ok2buy 3 years ago
I see the games are afoot here. Large asks coming into the block, looking to scare retailers holding the stock into selling lower. Don't be intimidated by institutions into selling your shares because they are buying them./ok2
👍️0
ok2buy ok2buy 3 years ago
Oversold on a Friday. Bought and will hold into next week. Good luck to all./ok2buy
👍️0
Jake L Jake L 3 years ago
VRPX - MIDDAY REPORT

👍️0
SurgeGuy2.0 SurgeGuy2.0 3 years ago
Another SCAM play? lolzzzzzz
👍️0
SurgeGuy2.0 SurgeGuy2.0 3 years ago
Ouch! CRASH AND BURN!!!!!! lolzzzzzzzzzzz No COXY ROXY here! lolzzzzz
👍️0
bcapps66 bcapps66 3 years ago
It happens....I was up going into the late afternoon so I went to the beach for an hour just to come back to a disaster haha.
👍️0
thepat45 thepat45 3 years ago
Yeah, not my finest moment for sure.
👍️0
dinogreeves dinogreeves 3 years ago
CHRS is the next big runner, has 50 dollars writen all over it by Monday next week.
👍️0
bcapps66 bcapps66 3 years ago
That didn't work out well....
👍️0
fitzwell11 fitzwell11 3 years ago
Everyone look at NURO on its run. Same pattern. Exploded to $40 they faded it all the way back to $21 then it gapped to
$40 next morning. I don’t think shorts are off the hook here yet. Just my .02
👍️0
thepat45 thepat45 3 years ago
After hours should be interesting then.. Looking for a large spike after close today.
👍️0
Pedro2004 Pedro2004 3 years ago
They're shorting, covering, shorting again, and covering again -- to shake this down.
👍️0
thepat45 thepat45 3 years ago
Can only short but so much... Float is around 2 million shares...
👍️0
Pedro2004 Pedro2004 3 years ago
Damn. They're shorting the hell out of this to keep it down.
👍️0
thepat45 thepat45 3 years ago
Sure, I'll go for a ride...
👍️0
budgetthis budgetthis 3 years ago
Turning over in the $20 + range nicely……..

Elevator going up ?

All Aboard ?

$$ VRPX $$
👍️0
SurgeGuy2.0 SurgeGuy2.0 3 years ago
100% complete BS!!!!! Sorry! lolzzzzzzzz
👍️0
makinezmoney makinezmoney 3 years ago
$VRPX: Get a good broker


Who's your broker ?


THey probably suck



GO $VRPX
👍️0
BUFCARP BUFCARP 3 years ago
They stopped it with the bs halt to save shorts..
👍️0
dinogreeves dinogreeves 3 years ago
I know of one reality, once I get out, I never get back in. Good luck though.
👍️0
Major_Bankz Major_Bankz 3 years ago
Reality here = only 2M Float, with this volume its going much higher.
👍️0
Major_Bankz Major_Bankz 3 years ago
2M Float should be locked by now, this runs to $50+
👍️0
eur06 eur06 3 years ago
True
👍️0
Major_Bankz Major_Bankz 3 years ago
maybe higher, 2M Float is just crazy low.
👍️0
makinezmoney makinezmoney 3 years ago
$VRPX: Catch the next VRPX at $PMCB right now


NO SHARES TO SHORT !!!!!!!



And HALTED right now.


You know how this works :)



GO $VRPX & $PMCB
👍️0
MonstaGains MonstaGains 3 years ago
Weeeeeeeeeee hahaha
👍️0
Major_Bankz Major_Bankz 3 years ago
Volatility halt, should open around $35+
👍️0
Major_Bankz Major_Bankz 3 years ago
looks like its holding strong, with 2M Float this runs to $50+ today
👍️0
cityimport cityimport 3 years ago
Thank you Dino!
congratulation to you too.

Let's get to the next BIG one ;)
👍️0
Major_Bankz Major_Bankz 3 years ago
they have not seen anything yet.
👍️0
dinogreeves dinogreeves 3 years ago
20 is too low, 25 will be minimum, but it is possible 21-22 will be the bottom.
👍️0
Major_Bankz Major_Bankz 3 years ago
this may dip to $20 at the open, after that it runs to $50
👍️0
MonstaGains MonstaGains 3 years ago
Shorts got screwed overnight bigtime lol
👍️0
MonstaGains MonstaGains 3 years ago
Hahaha weeeeeeee they bought some of my shares at 36 lol
👍️0
dinogreeves dinogreeves 3 years ago
Who knows what it will do, in my honest opinion it is worth at least 40 dollars, that is just about it for now
👍️0
Major_Bankz Major_Bankz 3 years ago
VRPX $50 maybe $80+ today!
👍️0
dinogreeves dinogreeves 3 years ago
You have to enable your account to extended hours trading.
👍️0
Major_Bankz Major_Bankz 3 years ago
VRPX will hit $50+ today
👍️0
eur06 eur06 3 years ago
Yes
👍️0
Tim696969 Tim696969 3 years ago
7 am EST right?
👍️0

Your Recent History

Delayed Upgrade Clock